Brief: DSM-Firmenich Initiates Patent Infringement Litigation In China
BRIEF-DSM-Firmenich Initiates Patent Infringement Litigation In China Aug 21 (Reuters) - DSM-Firmenich AG DSFIR.AS:
INITIATES PATENT INFRINGEMENT LITIGATION IN CHINA REGARDING PRODUCTION OF SCLAREOL VIA BIOTECHNOLOGY
REQUESTED THAT COURT ORDERS DEFENDANTS TO CEASE UNAUTHORIZED USE AND PROVIDE COMPENSATION FOR ALLEGED INFRINGEMENT
Further company coverage: DSFIR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on DSM-Firmenich AG
See all newsAnalysis: Brazil's corn ethanol boom accelerating growth of feedlot beef
Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK
Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Dsm-firmenich raises growth outlook in line with expectations (updated)